Surrozen (SRZN) Scheduled to Post Quarterly Earnings on Tuesday

Surrozen (NASDAQ:SRZN) will announce its earnings results on Tuesday, April 2nd.

Surrozen Price Performance

SRZN stock traded down $5.61 during mid-day trading on Monday, hitting $10.10. 222,090 shares of the stock were exchanged, compared to its average volume of 16,590. The stock has a market capitalization of $20.60 million, a price-to-earnings ratio of -0.58 and a beta of 0.74. Surrozen has a 12 month low of $4.50 and a 12 month high of $16.19. The business has a fifty day moving average price of $11.65 and a 200 day moving average price of $8.91.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SRZN. Vanguard Group Inc. grew its stake in shares of Surrozen by 3.2% in the 3rd quarter. Vanguard Group Inc. now owns 487,278 shares of the company’s stock valued at $984,000 after buying an additional 15,299 shares during the period. FMR LLC purchased a new stake in shares of Surrozen in the second quarter valued at about $744,000. Trustees of Columbia University in the City of New York acquired a new stake in shares of Surrozen during the fourth quarter worth $419,000. Bank of Montreal Can acquired a new stake in shares of Surrozen in the 1st quarter worth about $377,000. Finally, Morgan Stanley increased its stake in Surrozen by 10,427.8% during the 4th quarter. Morgan Stanley now owns 528,179 shares of the company’s stock valued at $307,000 after buying an additional 523,162 shares during the period. 66.57% of the stock is currently owned by institutional investors and hedge funds.

Surrozen Company Profile

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company is developing antibody-based therapeutics with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.